Treatment of HER2-positive Breast Carcinomatous Meningitis With Intrathecal Administration of Α-Particle-Emitting 211At-Labeled Trastuzumab
Nuclear Medicine and Biology - United States
doi 10.1016/j.nucmedbio.2009.04.003
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2009
Authors
Publisher
Elsevier BV